Usefulness of the TIMI Risk Index in predicting short- and long-term mortality in patients with acute coronary...

Area of Science:

• Cardiology
• Clinical Medicine
• Public Health

Background:

• Acute coronary syndromes (ACSs) encompass ST-elevation myocardial infarction (STEMI), non-STEMI, and unstable angina.
• Accurate risk stratification is crucial for managing ACS patients and predicting outcomes.
• The Thrombolysis In Myocardial Infarction (TIMI) Risk Index was initially validated for 30-day mortality in STEMI patients from clinical trials.

Purpose of the Study:

• To evaluate the predictive performance of the TIMI Risk Index for short- and long-term mortality in a broad cohort of unselected ACS patients.
• To assess the discrimination ability of the TIMI Risk Index across different ACS subtypes.
• To determine the utility of the TIMI Risk Index for stratifying long-term mortality risk in ACS.

Main Methods:

• A retrospective cohort study involving 710 patients diagnosed with ACS.
• Analysis of mortality outcomes (short- and long-term) in relation to TIMI Risk Index scores.
• Calculation of discrimination ability using c-statistics for the overall ACS cohort and specific subtypes.

Main Results:

• The TIMI Risk Index demonstrated strong predictive capability for both short- and long-term mortality in the overall ACS cohort.
• Good discrimination ability was observed, with c-statistics ranging from 0.77 to 0.79.
• The index proved effective across all ACS subtypes, including STEMI, non-STEMI, and unstable angina pectoris.

Conclusions:

• The TIMI Risk Index is a valuable tool for predicting mortality in unselected ACS patients, beyond its original indication.
• Its application can be extended to patients with non-STEMI and unstable angina, broadening its clinical utility.
• The index effectively stratifies long-term mortality risk, aiding in comprehensive patient management.